Targeting Notch3 in Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Perspectives

被引：32
|
作者：
Giovannini, Catia [1 ,2 ]
Bolondi, Luigi [1 ,2 ]
Gramantieri, Laura [1 ]
机构：
[1] S Orsola Malpighi Univ Hosp, Ctr Appl Biomed Res CRBA, I-40138 Bologna, Italy
[2] Univ Bologna, Dept Med & Surg Sci, I-40138 Bologna, Italy
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2017年 / 18卷 / 01期
关键词：
Notch; p53; hepatocellular carcinoma (HCC); GAMMA-SECRETASE INHIBITOR; ACUTE LYMPHOBLASTIC-LEUKEMIA; TUMOR-SUPPRESSOR FUNCTION; PANCREATIC-CANCER CELLS; HUMAN BREAST-CANCER; DOWN-REGULATION; SIGNALING PATHWAY; STEM-CELLS; RECEPTOR EXPRESSION; LATERAL INHIBITION;
D O I：
10.3390/ijms18010056
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The Notch signaling pathway is a very conserved system that controls embryonic cell fate decisions and the maintenance of adult stem cells through cell to cell communication. Accumulating evidence support the relevance of Notch signaling in different human diseases and it is one of the most commonly activated signaling pathways in cancer. This review focuses mainly on the role of Notch3 signaling in hepatocellular carcinoma and its potential therapeutic applications against this malignancy. In this regard, the crosstalk between Notch and p53 may play an important role.
引用
收藏
页数：13
相关论文
共 50 条
  • [31] Notch3 overexpression enhances progression and chemoresistance of urothelial carcinoma
    Zhang, Heng
    Liu, Limei
    Liu, Chungang
    Pan, Jinhong
    Lu, Gensheng
    Zhou, Zhansong
    Chen, Zhiwen
    Qian, Cheng
    ONCOTARGET, 2017, 8 (21) : 34362 - 34373
  • [32] Tumor suppressor role of Notch3 in medullary thyroid carcinoma
    Jaskula-Sztul, Renata
    Eide, Jacob
    Kunnimalaiyaan, Muthusamy
    Chen, Herbert
    CANCER RESEARCH, 2011, 71
  • [33] Antisense Oligonucleotides Targeting Notch3 Ameliorate Cortical Bone Osteopenia
    Canalis, Ernesto
    Mocarska, Magda
    Schilling, Lauren
    Jafar-nejad, Paymaan
    Carrer, Michele
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 237 - 237
  • [34] Peptides and recombinant proteins as strategy for targeting Notch3 in lung cancer
    Lin, Luping
    Yi, Fuming
    Blum, David
    Mernaugh, Ray
    Carbone, David P.
    Dang, Thao P.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S361 - S361
  • [35] Biliary tract carcinoma: clinical perspectives on molecular targeting strategies for therapeutic options
    Shoda, Junichi
    Ishige, Kazunori
    Sugiyama, Hiroaki
    Kawamoto, Toru
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2012, 19 (04) : 342 - 353
  • [36] miR-491-5p suppresses cell growth and invasion by targeting Notch3 in nasopharyngeal carcinoma
    Zhang, Qi
    Li, Qiang
    Xu, Tao
    Jiang, Hui
    Xu, Lin-Gen
    ONCOLOGY REPORTS, 2016, 35 (06) : 3541 - 3547
  • [37] Molecular perspectives for the treatment of hepatocellular carcinoma
    Demory, A.
    Nault, J. C.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2020, 83 (02) : 309 - 312
  • [38] A potential and novel therapeutic approach to ischemic heart diseases: Notch3
    Yi, Xin
    Feng, Gaoke
    Jiang, Xuejun
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 246 : 58 - 58
  • [39] Notch3 as a novel therapeutic target in metastatic medullary thyroid cancer
    Lou, Irene
    Odorico, Scott
    Yu, Xiao-Min
    Harrison, April
    Jaskula-Sztul, Renata
    Chen, Herbert
    SURGERY, 2018, 163 (01) : 104 - 110
  • [40] Molecular targeting of CSN5 in human hepatocellular carcinoma: a mechanism of therapeutic response
    Y-H Lee
    A D Judge
    D Seo
    M Kitade
    L E Gómez-Quiroz
    T Ishikawa
    J B Andersen
    B-K Kim
    J U Marquardt
    C Raggi
    I Avital
    E A Conner
    I MacLachlan
    V M Factor
    S S Thorgeirsson
    Oncogene, 2011, 30 : 4175 - 4184
12345